"Central retinal vein occlusion (CRVO) affects app
Post# of 30028
Posted On: 10/07/2014 9:29:11 AM
Quote:
"Central retinal vein occlusion (CRVO) affects approximately 100,000 patients in the United States, and 140,000 patients in Europe. The market is predicted to grow at approximately 16-18% per year. Companies that are marketing drugs targeting CRVO include Regeneron, Novartis, Roche and Bayer.
Glaucoma affects approximately 4 million people in the United States, with a total drug market size of approximately $3B.
"
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼